PolyPid – JoelGalvan

Business

PolyPid reports positive phase 3 surgical infection drug trial

5 min read

Posted on June 10, 2025

by Joelgalvan

Israeli late-stage biopharmaceutical company PolyPid (Nasdaq: PYPD) has reported positive Phase III trial results on its treatment for surgical…